Short, intense cold in a chilled chamber or cold water. Best-supported: less pain and disease activity in inflammatory joint disease, improved depression scores alongside ongoing treatment, less muscle soreness after hard exercise with cold water. Costs are real — cold soon after lifting reduces muscle growth, blood pressure rises during exposure, skin burns occur. Aging claims rest on animal work. (Full Review)

Protocol

Standard chamber protocol

2–3 min at −110 °C to −140 °C

6–10 sessions over 2–3 weeks, dry clothing, extremities covered

Standard immersion protocol

10–15 °C for 5–15 min

To the neck or waist, daily or several times weekly

Weekly dose framing

~11 min of cold per week

Across two to four sessions; extrapolated, not a tested prescription

Time to effect

Rheumatic disease symptom change

3–6 sessions

Pain and measured disease activity

Pain relief and mood lift

Immediate

Last hours

Metabolic acclimation effects

~10 days

Requires sustained exposure, not brief sessions

Benefits

High: Reduced pain and disease activity in inflammatory rheumatic conditions; reduced muscle soreness after exercise; reduced depressive symptoms alongside standard care

Medium: Fewer days of sickness absence; improved insulin sensitivity after mild cold acclimation; improved cognition in mild cognitive impairment

Low: Improved sleep quality and reduced training fatigue; improved blood lipids; increased cold-induced energy expenditure

Speculative: Slowed biological aging; suppressed tumour growth

Contraindications

Unstable ischaemic heart disease, angina, myocardial infarction (<90 days)

Uncontrolled hypertension (≥180/110 mmHg)

Symptomatic arrhythmia, long QT (>480 ms), defibrillator

Heart failure, New York Heart Association Class III–IV

Cold urticaria, cryoglobulinaemia, cold agglutinin disease, paroxysmal cold haemoglobinuria

Raynaud phenomenon with digital ulceration; peripheral arterial disease

Peripheral neuropathy with loss of protective sensation

Acute respiratory infection; poorly controlled or cold-triggered asthma

Untreated seizure disorder; unconsciousness risk in water

Pregnancy

Open wounds, active skin infection, recent frostbite

Alcohol or sedatives (diphenhydramine) before immersion

Key Interactions

Beta-blockers (metoprolol, atenolol, propranolol)

Vasoconstrictors (sumatriptan, ergotamine, pseudoephedrine)

Stimulants (amphetamines, methylphenidate, high-dose caffeine)

Anticoagulants, antiplatelets (warfarin, apixaban, aspirin)

Non-steroidal anti-inflammatory drugs (ibuprofen, naproxen)

High-dose antioxidants (vitamin C 1000 mg, vitamin E 400 IU)

Nitric-oxide boosters (citrulline, beetroot nitrate), yohimbine

Melatonin and evening sedatives

Sauna, heat therapy, contrast bathing

Resistance and blood-flow restriction training

Risk & Side Effects

High: Blunted muscle hypertrophy and strength adaptation; acute blood pressure rise and cardiac strain; cold shock and drowning risk in open water

Medium: Cold burns, frostbite and skin injury; hypothermia and afterdrop; prolonged cardiac repolarisation after long cold-water swims; cold urticaria and anaphylaxis

Low: Nitrogen asphyxiation in unsupervised partial-body devices; transient neurological and sensory adverse events; airway narrowing in asthma

Speculative: Suppression of beneficial inflammatory signalling beyond muscle; reduced brain-derived neurotrophic factor

Monitoring

Marker	Target	Why
High-sensitivity C-reactive protein	<1.0 mg/L	Tracks whether systemic inflammation falls
Resting blood pressure	<120/80 mmHg	A rising baseline is a stop signal
Corrected QT interval	<450 ms (men), <460 ms (women)	Screens for cold-related arrhythmia risk
Heart-rate variability (rMSSD)	Stable or rising against own 7-day baseline	Recovery gain versus added autonomic load
Fasting insulin	2–5 µIU/mL	Metabolic effect of sustained mild cold acclimation
HbA1c	4.8–5.4%	Whether insulin-sensitivity gain persists
Triglycerides	<80 mg/dL	The lipid fraction that moved most consistently
Total testosterone (men)	600–900 ng/dL	A falling trend suggests excessive load
Creatine kinase	<200 U/L at rest	Genuine recovery versus masked muscle damage
Thyroid-stimulating hormone	0.5–2.0 mIU/L	Sustained cold load can shift thyroid signalling

Cadence: Baseline before first exposure; reassessment at 4 and 12 weeks, then 6-monthly; blood pressure and skin checks weekly for the first month

Qualitative Assessment

Morning mood and sense of drive in the hours after a session
Joint stiffness and pain on a simple 0–10 scale, recorded weekly
Sleep latency and number of night awakenings
Cold tolerance: time to shivering onset, which tracks habituation
Training quality: readiness, perceived exertion at fixed loads, strength progression
Skin after each session: redness, itching or numbness beyond 30 minutes

Cryotherapy for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment